AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023
Aug 18, 2023
35599_dirs_2023-08-18_a16cc613-23ef-4d81-89d8-c5b09453c092.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-08-18
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-18 | Common Shares | S | 673 | $7.85 | Disposed | 43303 | Direct |
Footnotes
F1: Shares originally acquired through the exercise of an option with strike price of $0.45, and an original expiration date of August 17, 2022.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20